e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Proof of concept that most borderline Quantiferon results are true antigen-specific responses
Jonathan W. Uzorka, Lucia J.M. Kroft, Jaap A. Bakker, Erik W. van Zwet, Erik Huisman, Corine Knetsch-Prins, Cornelis J. van der Zwan, Tom H.M. Ottenhoff, Sandra M. Arend
Source:
Eur Respir J, 50 (5) 1701630; 10.1183/13993003.01630-2017
Journal Issue:
November
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jonathan W. Uzorka, Lucia J.M. Kroft, Jaap A. Bakker, Erik W. van Zwet, Erik Huisman, Corine Knetsch-Prins, Cornelis J. van der Zwan, Tom H.M. Ottenhoff, Sandra M. Arend. Proof of concept that most borderline Quantiferon results are true antigen-specific responses. Eur Respir J, 50 (5) 1701630; 10.1183/13993003.01630-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results
Source: Eur Respir J, 50 (4) 1701267; 10.1183/13993003.01267-2017
Year: 2017
Relationship of interferon-gamma release assay results and tuberculin skin test results to numbers of circulating CD4 T-cells in HIV–infection
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
IFN γ tests for tuberculosis – false positives with other T cell disease processes?
Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Year: 2008
Evaluation of tuberculin responsiveness and booster effect in HIV negative chronic hemodialysis patients and compare of their results with standard skin anergy test
Source: Eur Respir J 2005; 26: Suppl. 49, 417s
Year: 2005
The impact of absolute CD4+ and CD8+ T-cell counts on IGRA test results in HIV/AIDS patients
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011
IFN-γ T cell response in the diagnosis of latent tuberculosis infection in children with a positive tuberculin skin test
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
Memory response to RD1 antigens in TST+ subjects: a better tool to detect LTBI?
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008
The role of the ESAT-6/CFP-10 in whole blood IFN-gamma test in TB assessment
Source: Eur Respir J 2006; 28: Suppl. 50, 140s
Year: 2006
Diagnostic value of non-specific humoral immune changes in children investigated for tuberculosis by skin test and bacteriology
Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood
Year: 2011
Tuberculin-type dependent in vitro cell-mediated immunity in children differing by skin test results and BK status
Source: Annual Congress 2010 - Tuberculosis in children
Year: 2010
Pathogen prevalence may determine maintenance of antigen-specific T-cell responses in HIV-infected individuals
Source: Annual Congress 2010 - Tuberculosis and HIV coinfection
Year: 2010
Screening for latent TB using antigen-specific IP-10 response and the effect of prednisolon
Source: Annual Congress 2012 - New developments in the immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2012
Indeterminate results of a tuberculosis-specific interferon-γ release assay in immunocompromised patients
Source: Eur Respir J 2010; 35: 1179-1182
Year: 2010
Comparison of whole-blood interferon-gamma release assay and tuberculin skin test results for the prediction of active tuberculosis disease in HIV-infected individuals
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
When to apply which bronchial challenge test and interpretation of the results
Source: Annual Congress 2013 –New ATS/ERS recommendations for bronchial challenge testing
Year: 2013
Interpretation of TB-specific interferon gamma assays (T.SPOT-TB & QFT-GIT) in South Africa: boosting, reproducibility and the effect of lymphocyte count normalisation
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008
Tuberculosis-specific T-cell response after recent treatment and remote cure
Source: Eur Respir J 2011; 38: 1225-1228
Year: 2011
Indeterminate IFN-? release assay test results predict poor prognosis of active pulmonary tuberculosis
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
A new immune diagnostic assay based on ESAT-6 and CFP-10 epitopes in the evaluation of subjects with a clinical suspicion of active tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 427s
Year: 2004
The role of a new immuno-diagnostic test based on ESAT-6 epitopes in the screening of subjects with a clinical suspicion of active tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 166s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept